Fig. 4

Lenke types differences of plasma ccf DNA levels in AIS patients and controls. a, Concentration of plasma ccf n-DNA in AIS patients and controls by Lenke types; b, Concentration of plasma ccf mt-DNA in AIS patients and controls by Lenke types; c, d, ROC curves for ccf n-DNA and mt-DNA levels discriminating between L1 patients and controls; e, f, ROC curves for ccf n-DNA and mt-DNA levels discriminating between L5 patients and controls. *p < 0.05